RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION, REVIEW ACT
Impact
The impact of H7539 on existing state laws is significant as it introduces regulations that govern how insurance providers manage and approve prescriptions and treatments based on medical necessity. Under this law, health insurers will need to provide detailed data to the Rhode Island Department of Health Insurance regarding the effectiveness of their step therapy protocols, particularly focusing on whether these protocols delay or deny necessary medical care. This requirement aims to align state regulations with the evolving landscape of healthcare delivery, placing greater emphasis on patient-centric care.
Summary
House Bill H7539 aims to limit the use of step therapy by insurers, a management protocol that requires patients to try and fail on less expensive treatments before they can access more costly medications prescribed by their healthcare providers. The bill allows healthcare professionals to request exceptions to step therapy requirements, especially when they deem that such protocols could result in delays or denials of medically necessary care. By assuring easier access to prescribed treatments, H7539 seeks to enhance patient care and support medical professionals' decisions in treatment plans.
Contention
Despite the potential benefits of H7539, the bill has sparked debate among stakeholders. Proponents, including many healthcare advocates, argue that the current step therapy practices hinder access to essential medications for patients suffering from chronic and severe conditions. However, opponents express concerns regarding the administrative burdens that insurers may face in adjusting their protocols to align with the new law. Some also worry about the increased costs associated with expanding coverage for more expensive medications as a result of the loosening of these step therapy requirements.